Discovery of a functionally selective ghrelin receptor (GHSR 1a ) ligand for modulating brain dopamine is a research paper published in Proceedings of the National Academy of Sciences (2022). On theSindex it has a DataRank of 0. It has been cited 18 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
HHS | NIH | National Institute on Drug Abuse
Grant: F32DA051139
HHS | NIH | National Institute on Drug Abuse
Grant: U18DA052417
HHS | NIH | National Institute on Drug Abuse
Grant: P30DA029925
HHS | NIH | National Institute of Mental Health
Grant: R37MH073853
HHS | NIH | National Center for Advancing Translational Sciences
Grant: ZIATR000083
National Institutes of Health
Grant: 1U18DA052417-01
A novel functionally selective drug for the treatment of cocaine abuse by antagonism of the beta-arrestin signaling arm of the Ghrelin Receptor
National Institutes of Health
Grant: 5F32DA051139-03
Exploiting Biased Agonism at the Ghrelin Receptor (GHSR1a) for Opioid Addiction
National Institutes of Health
Grant: 5R37MH073853-15
Akt/GSK-3 Signaling Cascade and the Actions of Dopamine
National Institutes of Health
Grant: 1ZIATR000083-11
Identification of small molecule that selectively modulate Ghrelin receptor (GHSR1a) b-arrestin signaling as a new therapeutic approach for the treatment of addiction
National Institutes of Health
Grant: 3P30DA029925-05S1
Drug Abuse: Discovering Ligands for Pertinent GPCRs
NIDA NIH HHS
Grant: R00 DA048970
FWCI
1.58
Citation Percentile
0.8%
Citation Trend
Fields of Study
MeSH Terms
Keywords
Sustainable Development Goals